FindTrial
Sign In

the Prognostic Factors for Ovarian Metastasis in Patients with Endometrial Cancer

the Prognostic Factors for Ovarian Metastasis in Patients with Endometrial Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800018312
Enrollment
Unknown
Registered
2018-09-11
Start date
2018-10-01
Completion date
Unknown
Last updated
2018-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endometrial cancer

Interventions

endometrial cancer case series:hysterectomy and oophorectomy

Sponsors

Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1) surgery was the initial treatment and no other treatments, such as radiotherapy, chemotherapy, hormonal therapy and targeted therapy, were performed before surgery; 2) endometrial cancer was diagnosed by postoperative pathological analysis.

Exclusion criteria

Exclusion criteria: 1) surgery was not the initial treatment and no other treatments, such as radiotherapy, chemotherapy, hormonal therapy and targeted therapy, were performed before surgery; 2) history of noncancerous ovarian tumors or malignant ovarian tumors; 3) coexisting malignancies.

Design outcomes

Primary

MeasureTime frame
incidence of ovarian metastasis in patients with endometrial cancer and the possible risk factors;—

Countries

China

Contacts

Public ContactHuaiwu Lu

Sun Yat-sen Memorial Hospital, Sun Yat-sen University

luhuaiwu@163.com+86 18688395806

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026